http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-WO2011068206-A1

Outgoing Links

Predicate Object
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12P41-006
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12P13-06
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N9-80
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12P41-00
filingDate 2010-12-03-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 2013-04-18-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber JP-WO2011068206-A1
titleOfInvention Process for producing optically active amino acid or optically active amino acid amide
abstract The present invention relates to an enzyme that stereoselectively hydrolyzes DL-tert-leucinamide, a microbial cell having the enzyme, a treated product of the microbial cell, and an immobilized enzyme in which the enzyme is immobilized on a carrier. Hydrolysis with the action of a biocatalyst selected from the group consisting of an immobilized microbial cell in which the microbial cell is immobilized on a carrier, and an immobilized microbial cell product in which the treated microbial cell product is immobilized on a carrier To produce D- or L-tert-leucine or D- or L-tert-leucine amide, wherein the hydrolysis is carried out while separating the ammonia produced by the hydrolysis from the hydrolysis reaction solution. It relates to a method characterized in that it is performed. According to the present invention, in an enzymatic reaction for stereoselectively hydrolyzing an amino acid amide, the activity per unit time is maintained high by maintaining the activity per enzyme or bacterial body or its treated product and per unit time. The concentration of the raw material amino acid amide in the reaction solution can be increased without increasing the amount of acid, and as a result, the optically active tert-leucine or optically active tert-leucine amide can be produced without increasing the generation of waste salts and waste cells. Productivity can be greatly improved.
priorityDate 2009-12-04-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426124734
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID26003
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426185960
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID448215830
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3496444
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID8041
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID34073
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID10197708
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID222
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID28320
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID420969925
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID40837
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID281
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11966249
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID281
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419490523
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6106
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID306131
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419514448
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6950339
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCO01945
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415933046
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID28320
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419550829
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11297986
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID422119153
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID34073
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID410578480
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID40837

Total number of triples: 40.